{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:32:28Z","timestamp":1789687948691,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"King Saud University, Riyadh","award":["ORF-2025-734"],"award-info":[{"award-number":["ORF-2025-734"]}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["DOI:10.54499\/UIDP\/04378\/2020 and DOI:10.54499\/UIDB\/04378\/2020"],"award-info":[{"award-number":["DOI:10.54499\/UIDP\/04378\/2020 and DOI:10.54499\/UIDB\/04378\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015621","name":"UCIBIO","doi-asserted-by":"crossref","award":["LA\/P\/0140\/2020"],"award-info":[{"award-number":["LA\/P\/0140\/2020"]}],"id":[{"id":"10.13039\/501100015621","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-26292-7","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T02:55:33Z","timestamp":1768532133000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chemical synthesis, bioinformatics and antiproliferative studies of novel pyrimidin-4-yl-1H-pyrazole derivatives in chronic myeloid cancer cells"],"prefix":"10.1038","volume":"16","author":[{"given":"K. V.","family":"Rajasheker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. S.","family":"Pallavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. C.","family":"Arun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Stupin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzaffar","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Roma-Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro V.","family":"Baptista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra R.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Silina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva Prasad","family":"Kollur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"26292_CR1","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S0140-6736(16)30376-2","volume":"388","author":"GA Colditz","year":"2016","unstructured":"Colditz, G. A. & Emmons, K. M. The role of universal health coverage in reducing cancer deaths and disparities. Lancet 388, 638\u2013640. https:\/\/doi.org\/10.1016\/S0140-6736(16)30376-2 (2016).","journal-title":"Lancet"},{"key":"26292_CR2","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/cncr.33587","volume":"127","author":"F Bray","year":"2021","unstructured":"Bray, F., Laversanne, M., Weiderpass, E. & Soerjomataram, I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer 127, 3029\u20133030. https:\/\/doi.org\/10.1002\/cncr.33587 (2021).","journal-title":"Cancer"},{"key":"26292_CR3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer. J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer. J. Clin."},{"key":"26292_CR4","doi-asserted-by":"publisher","unstructured":"Brody, T. Chapter 17\u2014Hematological cancers. In Clinical Trials, 279\u2013325. (Academic Press, 2012). https:\/\/doi.org\/10.1016\/B978-0-12-391911-3.00017-7","DOI":"10.1016\/B978-0-12-391911-3.00017-7"},{"issue":"22","key":"26292_CR5","doi-asserted-by":"publisher","first-page":"12516","DOI":"10.3390\/ijms222212516","volume":"22","author":"B Abdulmawjood","year":"2021","unstructured":"Abdulmawjood, B., Costa, B., Roma-Rodrigues, C., Baptista, P. V. & Fernandes, A. R. Genetic biomarkers in chronic myeloid leukemia: What have we learned so far?. Int. J. Mol. Sci. 22(22), 12516. https:\/\/doi.org\/10.3390\/ijms222212516 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"26292_CR6","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1056\/NEJMoa055104","volume":"354","author":"H Kantarjian","year":"2006","unstructured":"Kantarjian, H. et al. Nilotinib in imatinib-resistant CML and philadelphia chromosome-positive ALL. N. Engl. J. Med. 354, 2542\u20132551. https:\/\/doi.org\/10.1056\/NEJMoa055104 (2006).","journal-title":"N. Engl. J. Med."},{"key":"26292_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104028","volume":"101","author":"Z Kilic-Kurt","year":"2020","unstructured":"Kilic-Kurt, Z., Ozmen, N. & Bakar-Ates, F. Synthesis and anticancer activity of some pyrimidine derivatives with aryl urea moieties as apoptosis-inducing agents. Bioorg. Chem. 101, 104028. https:\/\/doi.org\/10.1016\/j.bioorg.2020.104028 (2020).","journal-title":"Bioorg. Chem."},{"key":"26292_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2020.112458","volume":"200","author":"Z-X He","year":"2020","unstructured":"He, Z.-X. et al. Pyrimidine: A promising scaffold for optimization to develop the inhibitors of ABC transporters. Eur. J. Med. Chem. 200, 112458. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112458 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"26292_CR9","doi-asserted-by":"publisher","first-page":"102934","DOI":"10.1016\/j.bioorg.2019.102934","volume":"88","author":"OG Shaaban","year":"2019","unstructured":"Shaaban, O. G. et al. Synthesis and molecular docking study of some 3,4-dihydrothieno[2,3-d]pyrimidine derivatives as potential antimicrobial agents. Bioorg. Chem. 88, 102934. https:\/\/doi.org\/10.1016\/j.bioorg.2019.102934 (2019).","journal-title":"Bioorg. Chem."},{"key":"26292_CR10","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.ejmech.2018.07.039","volume":"156","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. 6-Arylthio-3-hydroxypyrimidine-2,4-diones potently inhibited HIV reverse transcriptase-associated RNase H with antiviral activity. Eur. J. Med. Chem. 156, 652\u2013665. https:\/\/doi.org\/10.1016\/j.ejmech.2018.07.039 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"26292_CR11","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1021\/acs.jmedchem.5b00037","volume":"58","author":"LY Ma","year":"2015","unstructured":"Ma, L. Y. et al. Design, synthesis, and structure-activity relationship of novel LSD1 inhibitors based on pyrimidine-thiourea hybrids as potent, orally active antitumor agents. J. Med. Chem. 58, 1705\u20131716. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00037 (2015).","journal-title":"J. Med. Chem."},{"key":"26292_CR12","doi-asserted-by":"publisher","first-page":"869","DOI":"10.2174\/1389557516666160923125801","volume":"17","author":"S Prachayasittikul","year":"2017","unstructured":"Prachayasittikul, S. et al. Roles of pyridine and pyrimidine derivatives as privileged scaffolds in anticancer agents. Mini Rev. Med. Chem. 17, 869\u2013901. https:\/\/doi.org\/10.2174\/1389557516666160923125801 (2017).","journal-title":"Mini Rev. Med. Chem."},{"key":"26292_CR13","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1016\/j.bmcl.2013.01.019","volume":"23","author":"KG Pike","year":"2013","unstructured":"Pike, K. G. et al. Optimization of potent and selective dual mTORC1 and mTORC2 inhibitors: The discovery of AZD8055 and AZD2014. Bioorg. Med. Chem. Lett. 23, 1212\u20131216. https:\/\/doi.org\/10.1016\/j.bmcl.2013.01.019 (2013).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"26292_CR14","doi-asserted-by":"publisher","first-page":"7618","DOI":"10.1073\/pnas.0307512101","volume":"101","author":"Y Gao","year":"2004","unstructured":"Gao, Y., Dickerson, J. B., Guo, F., Zheng, J. & Zheng, Y. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc. Natl. Acad. Sci. USA 101, 7618\u20137623. https:\/\/doi.org\/10.1073\/pnas.0307512101 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"26292_CR15","volume":"8","author":"S Rangaswamy","year":"2023","unstructured":"Rangaswamy, S. et al. Design and synthesis of oxazole-linked pyrazole chalcone derivatives: In-vitro anticancer evaluation and In-silico molecular docking studies. Chem. Select 8, e202302395 (2023).","journal-title":"Chem. Select"},{"key":"26292_CR16","doi-asserted-by":"publisher","first-page":"4166","DOI":"10.1007\/s00044-015-1457-y","volume":"24","author":"MdJ Ahsan","year":"2015","unstructured":"Ahsan, Md. J. et al. Synthesis, antiproliferative activity, and molecular docking studies of curcumin analogues bearing pyrazole ring. Med. Chem. Res. 24, 4166\u20134180 (2015).","journal-title":"Med. Chem. Res."},{"key":"26292_CR17","unstructured":"Arun, B., Brahmaiah, M., Sreenivasulu, R., Sravani, D., Dodda, S., Kapavarapu, R. K. & Krishnaswamy, S. Rational design and synthesis of 1,2,3-triazole incorporated oxazolo[5,4-d] pyrimidine derivatives: In-vitro cytotoxicity and In-silico molecular docking simulations. Polycyclic Aromatic Compd. (2025)."},{"key":"26292_CR18","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/00397911.2025.2457440","volume":"55","author":"VR Babu","year":"2025","unstructured":"Babu, V. R. et al. Design, synthesis, anticancer evaluation and molecular docking studies of different aryl derivatives of azaindole-pyrimidine-1,3,4-oxadiazoles. Synth. Commun. 55, 405\u2013421 (2025).","journal-title":"Synth. Commun."},{"key":"26292_CR19","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s11696-024-03861-0","volume":"79","author":"ER Devi","year":"2025","unstructured":"Devi, E. R. et al. Design, synthesis, in-vitro and in-silico anticancer studies on amide derivatives of 1,3,4-oxadiazole-isoxazol-pyridine-benzimidazole. Chem. Pap. 79, 1385\u20131405 (2025).","journal-title":"Chem. Pap."},{"key":"26292_CR20","doi-asserted-by":"crossref","unstructured":"Raghavender, G., Chandrasekhar, C. H., Kapavarapu, R. K. & Sreenivasulu, R. Synthesis of amide derivatives of pyrimidine-triazolo[1,5-a]pyridin-7-yl)thiazoles: in vitro anticancer evaluation and in silico molecular binding studies. Arab. J. Sci. Eng. (2024).","DOI":"10.1007\/s13369-024-09685-0"},{"key":"26292_CR21","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1080\/10406638.2021.1939067","volume":"42","author":"CM Bandaru","year":"2022","unstructured":"Bandaru, C. M. et al. Design, synthesis, anticancer evaluation and molecular docking studies of thiazole-pyrimidine linked amide derivatives. Polycycl. Aromat. Compd. 42, 5368\u20135384 (2022).","journal-title":"Polycycl. Aromat. Compd."},{"key":"26292_CR22","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1021\/acs.jchemed.5b00404","volume":"93","author":"C Zardecki","year":"2016","unstructured":"Zardecki, C., Dutta, S., Goodsell, D. S., Voigt, M. & Burley, S. K. RCSB protein data bank: A resource for chemical, biochemical, and structural explorations of large and small biomolecules. J. Chem. Educ. 93, 569\u2013575. https:\/\/doi.org\/10.1021\/acs.jchemed.5b00404 (2016).","journal-title":"J. Chem. Educ."},{"issue":"16","key":"26292_CR23","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M. et al. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 30(16), 2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256 (2009).","journal-title":"J. Comput. Chem."},{"issue":"7","key":"26292_CR24","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/bioinformatics\/btt055","volume":"29","author":"S Pronk","year":"2013","unstructured":"Pronk, S. et al. Gromacs 45: A high-throughput and highly parallel open source molecular simulation toolkit. Bioinformatics 29(7), 845\u2013854. https:\/\/doi.org\/10.1093\/bioinformatics\/btt055 (2013).","journal-title":"Bioinformatics"},{"issue":"2","key":"26292_CR25","doi-asserted-by":"publisher","first-page":"024503","DOI":"10.1063\/1.2136877","volume":"124","author":"Y Wu","year":"2006","unstructured":"Wu, Y., Tepper, H. L. & Voth, G. A. Flexible simplepoint-charge water model with improved liquid-state properties. J. Chem. Phys. 124(2), 024503. https:\/\/doi.org\/10.1063\/1.2136877 (2006).","journal-title":"J. Chem. Phys."},{"issue":"8","key":"26292_CR26","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1002\/prot.22711","volume":"78","author":"K Lindorff-Larsen","year":"2010","unstructured":"Lindorff-Larsen, K. et al. Improved side-chaintorsion potentials for the amber ff99sb protein force field. Proteins Struct. Funct. Bioinform. 78(8), 1950\u20131958. https:\/\/doi.org\/10.1002\/prot.22711 (2010).","journal-title":"Proteins Struct. Funct. Bioinform."},{"issue":"16","key":"26292_CR27","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/jcc.20290","volume":"26","author":"DA Case","year":"2005","unstructured":"Case, D. A. et al. The amber biomolecular simulation programs. J. Comput. Chem. 26(16), 1668\u20131688. https:\/\/doi.org\/10.1002\/jcc.20290 (2005).","journal-title":"J. Comput. Chem."},{"issue":"9","key":"26292_CR28","doi-asserted-by":"publisher","first-page":"3878","DOI":"10.1021\/ct400314y","volume":"9","author":"R Salomon-Ferrer","year":"2013","unstructured":"Salomon-Ferrer, R., Gotz, A. W., Poole, D., Le Grand, S. & Walker, R. C. Routine microsecond molecular dynamics simulations with amber on gpus. 2. Explicit solvent particlemesh ewald. J Chem Theory Comput 9(9), 3878\u20133888. https:\/\/doi.org\/10.1021\/ct400314y (2013).","journal-title":"J Chem Theory Comput"},{"issue":"9","key":"26292_CR29","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1021\/ct300418h","volume":"8","author":"BR Miller III","year":"2012","unstructured":"Miller, B. R. III. et al. MMPBSA. py: An efficient program for end-state free energy calculations. J. Chem. Theory Comput. 8(9), 3314\u20133321. https:\/\/doi.org\/10.1021\/ct300418h (2012).","journal-title":"J. Chem. Theory Comput."},{"issue":"11","key":"26292_CR30","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/cmdc.201600182","volume":"11","author":"A Daina","year":"2016","unstructured":"Daina, A. & Zoete, V. A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem 11(11), 1117\u20131121. https:\/\/doi.org\/10.1002\/cmdc.201600182 (2016).","journal-title":"ChemMedChem"},{"key":"26292_CR31","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717. https:\/\/doi.org\/10.1038\/srep42717 (2017).","journal-title":"Sci. Rep."},{"key":"26292_CR32","doi-asserted-by":"publisher","first-page":"2300090","DOI":"10.1002\/ppsc.202300090","volume":"41","author":"B Abdulmawjood","year":"2024","unstructured":"Abdulmawjood, B., Roma-Rodrigues, C., Baptista, P. V. & Fernandes, A. R. Tackling imatinib resistance via Au-nanoconjugates using A Cml resistant cell line. Part. Part. Syst. Charact. 41, 2300090. https:\/\/doi.org\/10.1002\/ppsc.202300090 (2024).","journal-title":"Part. Part. Syst. Charact."},{"key":"26292_CR33","doi-asserted-by":"publisher","first-page":"9126","DOI":"10.1039\/C8NJ01033A","volume":"42","author":"K Das","year":"2018","unstructured":"Das, K. et al. EPR and electrochemical interpretation of bispyrazolylacetate anchored Ni(II) and Mn(II) complexes: Cytotoxicity and anti-proliferative activity towards human cancer cell lines. New J. Chem. 42, 9126\u20139139. https:\/\/doi.org\/10.1039\/C8NJ01033A (2018).","journal-title":"New J. Chem."},{"issue":"2","key":"26292_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1021\/ed072p119","volume":"72","author":"AD Attie","year":"1995","unstructured":"Attie, A. D. & Raines, R. T. Analysis of receptor-ligand interactions. J. Chem. Educ. 72(2), 119\u2013124. https:\/\/doi.org\/10.1021\/ed072p119 (1995).","journal-title":"J. Chem. Educ."}],"updated-by":[{"DOI":"10.1038\/s41598-026-39213-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26292-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26292-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26292-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T14:58:57Z","timestamp":1770303537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-26292-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["26292"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-26292-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-39213-z","URL":"https:\/\/doi.org\/10.1038\/s41598-026-39213-z","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2229"}}